Cerus Corp (CERS) Stock Price, Quote & News

Company Profile

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets an...

Industry: Medical Devices

Sector: Healthcare

Phone: 925 288 6000

Website: www.cerus.com

Address:

1220 Concord Avenue, Suite 600, Concord, United States

AtomicAIerts Dec. 5 at 11:37 AM

$CERS AtomicAlerts Scalp Alert Direction: LONG Entry: $2.11 TP1: $2.81 | TP2: $3.51 | TP3: $4.21 Stop Loss: $1.51 👉 https://atomicalerts.com

0 · Reply

Iightning Dec. 5 at 6:21 AM

1ightning® Premium Options Alert (Actionable) Ticker: $CERS Contract: Dec 19 $1C Entry: 0.92 Exit: 1.24 Return: +34.15% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 5 at 12:10 AM

1ightning® Premium Options Alert (Actionable) Ticker: $CERS Contract: Dec 19 $1C Entry: 0.92 Exit: 1.24 Return: +34.15% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

BeefStewart Dec. 4 at 9:05 PM

$CERS congrats everyone. This is going extremely well!

1 · Reply

macroaxis Dec. 4 at 12:16 PM

$CERS - Volatility Surge Alert: Rising Pin Risk in Cerus Options – Stay Cautious https://www.macroaxis.com/stock-options/CERS/Cerus?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

Iightning Dec. 4 at 7:49 AM

1ightning® Premium Options Alert (Actionable) Ticker: $CERS Contract: Dec 19 $1.5C Entry: 0.55 Exit: 0.75 Return: +36.56% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

OldManLogan Dec. 3 at 4:01 PM

$CERS Torn on this one... because on the one hand; when I look at how much they are already generating without RBC and that RBC is literally 3X as big as everything else they do combined, lol, I'm thinking this is the next $ADMA for me... on the other hand, I only have 40k shares accumulated so far and want over 100k, so I don't want people knowing about this yet. Lmao.

2 · Reply

N8LongShort Dec. 3 at 3:36 PM

$CERS just moved above all moving averages really bullish for breakout.. wonder if someone bigger is scaling in.. paytience

0 · Reply

Violenteer Dec. 3 at 11:23 AM

$CERS Let's break 2.

0 · Reply

slacker53 Dec. 2 at 8:08 PM

@BeefStewart Did you get back into $CERS bro?

1 · Reply

Cerus: IFC Growth And RBC Optionality

Nov 6, 2025, 7:06 PM EST - 4 weeks ago

Cerus Corporation (CERS) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:01 PM EST - 4 weeks ago

Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

Oct 21, 2025, 8:30 AM EDT - 6 weeks ago

Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting

Oct 16, 2025, 4:00 PM EDT - 7 weeks ago

Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025

Aug 25, 2025, 9:00 AM EDT - 3 months ago

The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

Aug 21, 2025, 8:30 AM EDT - 3 months ago

Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

Aug 5, 2025, 9:02 PM EDT - 4 months ago

Cerus Corporation (CERS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:01 PM EDT - 4 months ago

Cerus Corporation Announces Second Quarter 2025 Financial Results

Jul 22, 2025, 4:15 PM EDT - 4 months ago

Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025

Jul 21, 2025, 8:30 AM EDT - 4 months ago

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury

Jul 2, 2025, 8:30 AM EDT - 5 months ago

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

Jun 13, 2025, 4:01 PM EDT - 6 months ago

Cerus Corporation Celebrates World Blood Donor Day 2025

Jun 3, 2025, 4:30 PM EDT - 6 months ago

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 29, 2025, 8:30 AM EDT - 6 months ago

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

May 28, 2025, 8:30 AM EDT - 6 months ago

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

May 1, 2025, 8:26 PM EDT - 7 months ago

Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript

May 1, 2025, 4:00 PM EDT - 7 months ago

Cerus Corporation Announces First Quarter 2025 Financial Results

Apr 17, 2025, 8:30 AM EDT - 8 months ago

Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

Mar 5, 2025, 1:00 PM EST - 9 months ago

Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

Feb 20, 2025, 9:50 PM EST - 10 months ago

Cerus Corporation (CERS) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:00 PM EST - 10 months ago

Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

Feb 19, 2025, 4:00 PM EST - 10 months ago

Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 7, 2025, 8:30 AM EST - 10 months ago

Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025

Jan 13, 2025, 8:30 AM EST - 11 months ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update

Nov 13, 2024, 8:30 AM EST - 1 year ago

Cerus Corporation to Participate in Upcoming Investor Conferences

Oct 30, 2024, 11:52 PM EDT - 1 year ago

Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Third Quarter 2024 Financial Results

Oct 18, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024

Oct 18, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting

Oct 16, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe

Aug 1, 2024, 8:29 PM EDT - 1 year ago

Cerus Corporation (CERS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024

Jul 2, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors

Jun 21, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion

Jun 14, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Celebrates World Blood Donor Day 2024

May 22, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference

May 2, 2024, 7:37 PM EDT - 1 year ago

Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript

May 2, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces First Quarter 2024 Financial Results

Apr 18, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024

Mar 26, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life

Mar 19, 2024, 8:00 AM EDT - 1 year ago

Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients

Mar 5, 2024, 6:43 PM EST - 1 year ago

Cerus Corporation (CERS) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 4:00 PM EST - 1 year ago

Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results

Feb 20, 2024, 8:30 AM EST - 1 year ago

Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024

Jan 15, 2024, 9:30 AM EST - 2 years ago

3 Growth Stocks That Could Go Parabolic in 2024

ABCL TSHA

Jan 8, 2024, 8:30 AM EST - 2 years ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update

Nov 2, 2023, 10:52 PM EDT - 2 years ago

Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 4:00 PM EDT - 2 years ago

Cerus Corporation Announces Third Quarter 2023 Financial Results

AtomicAIerts Dec. 5 at 11:37 AM

$CERS AtomicAlerts Scalp Alert Direction: LONG Entry: $2.11 TP1: $2.81 | TP2: $3.51 | TP3: $4.21 Stop Loss: $1.51 👉 https://atomicalerts.com

0 · Reply

Iightning Dec. 5 at 6:21 AM

1ightning® Premium Options Alert (Actionable) Ticker: $CERS Contract: Dec 19 $1C Entry: 0.92 Exit: 1.24 Return: +34.15% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 5 at 12:10 AM

1ightning® Premium Options Alert (Actionable) Ticker: $CERS Contract: Dec 19 $1C Entry: 0.92 Exit: 1.24 Return: +34.15% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

BeefStewart Dec. 4 at 9:05 PM

$CERS congrats everyone. This is going extremely well!

1 · Reply

macroaxis Dec. 4 at 12:16 PM

$CERS - Volatility Surge Alert: Rising Pin Risk in Cerus Options – Stay Cautious https://www.macroaxis.com/stock-options/CERS/Cerus?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

Iightning Dec. 4 at 7:49 AM

1ightning® Premium Options Alert (Actionable) Ticker: $CERS Contract: Dec 19 $1.5C Entry: 0.55 Exit: 0.75 Return: +36.56% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

OldManLogan Dec. 3 at 4:01 PM

2 · Reply

N8LongShort Dec. 3 at 3:36 PM

$CERS just moved above all moving averages really bullish for breakout.. wonder if someone bigger is scaling in.. paytience

0 · Reply

Violenteer Dec. 3 at 11:23 AM

$CERS Let's break 2.

0 · Reply

slacker53 Dec. 2 at 8:08 PM

@BeefStewart Did you get back into $CERS bro?

1 · Reply

VolumePrice Dec. 2 at 7:04 PM

$CERS added

0 · Reply

huma_44 Dec. 2 at 4:30 PM

$CERS hold for a year and sell it above 5

0 · Reply

bobmoney Dec. 2 at 2:05 PM

$CERS What is the exit strategy for CERS? Great blood product...but flat line on price for years, with almost 400 million shares outstanding...

0 · Reply

N8LongShort Dec. 2 at 1:52 PM

$CERS 2.50 is the next magic leap

0 · Reply

Iightning Dec. 2 at 2:16 AM

**1ightning® Premium Options Alert (Actionable)** **Ticker:** $CERS **Contract:** Dec 19 $1C **Entry:** 0.80 **Exit:** 0.99 **Return:** **+23.92% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**

0 · Reply

Violenteer Dec. 1 at 7:22 PM

$CERS Going higher.

0 · Reply

BiopharmaRN Nov. 29 at 12:33 AM

$AKBA $BCRX $CERS $CHRS $ESPR @Me0wth I have really enjoyed your posts! How about keeping it or part of it going. Maybe take your profit off your winner or if you have totally given up on one or two remove them. I and I’m sure others would really like to see it continue. Thanks!

3 · Reply

Me0wth Nov. 28 at 8:07 PM

$AKBA $BCRX $CERS $CHRS $ESPR 1 year bio tech challenge. 5 bio techs, 1000 dollars in each. No adding, no selling for 1 year. Started on November 29, 2024 ESPR holding everyone up, AKBA was the big winner until the recent destruction. Will sell in a week or two and move on in life 🤪

2 · Reply

N8LongShort Nov. 26 at 1:54 PM

$CERS once they are profitable this will move past 5 bucks and then the real magic happens, lot more institutional eyes

0 · Reply

Iightning Nov. 26 at 5:12 AM

1ightning® Options Trade Alert (Actionable) | Buy $CERS Dec 19 $2 Call | Enter: $0.05 Exit: $0.06 | Profit: 25.88% ROI | https://1ightning.com

0 · Reply

Stockboi_ Nov. 25 at 9:09 PM

$CERS strong close

0 · Reply

Me0wth Nov. 25 at 8:19 PM

$AKBA $BCRX $CERS $CHRS $ESPR 1 year bio tech challenge. 5 bio techs, 1000 dollars in each. No adding, no selling for 1 year. Started on November 29, 2024 ESPR stepping up to the plate at the last minute 😜

4 · Reply

Market Cap	359.21M
Revenue (ttm)	201.32M
Net Income (ttm)	-20.92M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-10.39%
Debt to Equity Ratio	1.37

Volume	1,534,100
Avg Vol	1,311,958
Day's Range	N/A - N/A
Shares Out	192.09M
Stochastic %K	98%
Beta	1.55
Analysts	Strong Sell
Price Target	$4.67